zurück

EU-HTA

#

Access Briefing: Germany Q4/24

11.04.2025
Get our latest update on HTA in Germany (AMNOG): ....
#

Lichtenstein, Norway and Iceland join the EU HTA family

03.04.2025
EU HTA Expands to 30 Countries! ...
#

New PICO Exercises Released: What Can We Learn?

01.04.2025
Evoque & PICO: Is One Enough? ...
#

New PICO Exercises Released: What Can We Learn?

19.03.2025
Why has publication taken that long? ...
#

New PICO Exercises Released: What Can We Learn?

14.03.2025
PICO Exercise for Accelerated Assessment!...
#

Key Updates on AMNOG & EU HTA Alignment

13.03.2025
Thrilling news ahead: the previously proposed 3-month suspension of the AMNOG process is not included in the final version of the First Regulation Amending the Ordinance on the Benefit Assessment of Medicinal Products...
#

IQWiG Allgemeine Methoden

11.03.2025
IQWiG just published the draft of their General Methods 8.0 but does not propose separate methods for EU HTA...
#

New PICO Exercises Released: What Can We Learn?

04.03.2025
Lots of PICOs again - 3 of them just for the G-BA?...
#

New PICO Exercises Released: What Can We Learn?

26.02.2025
Lots of PICOs and only one of two PICOs for German AMNOG covered!...
#

New PICO Exercises Released: What Can We Learn?

19.02.2025
Why has publication taken that long?...
#

New PICO Exercises Released: What Can We Learn?

12.02.2025
Exciting news from the Coordination Group: Second wave of PICO exercises published!...
#

Guidance on scoping (G05) published 

17.01.2025
G05 defines the essence of the respective HTA ...

 

Ansprechpartner

Dr. Thomas Ecker

Dr. Thomas Ecker
Tel. +49 (40) 41 33 081-10

 

Janine Leismann

Janine Leismann
Tel. +49 (40) 41 33 081-26